-
平臺編號：bio-49460
-
國際編號：ATCC VR-1355
-
拉丁屬名： Chlamydophila pneumoniae deposited
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Chlamydophila pneumoniae deposited
ATCC? Number:VR-1355?
Classification: Chlamydiacea, Chlamydophila
Agent: Chlamydophila pneumoniae deposited as Chlamydia pneumoniae Grayston et al.
Strain: TWAR strain 2043
Original Source: nasopharynx of human patient with pneumonia
Depositors: MR Hammerschlag
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : HEp-2 cells (ATCCCCL-23) HeLa 229 cells (ATCCCCL-2.1) human; human cell lines
Incubation : Atmosphere: 5% CO2 in air recommended Temperature: 35.0°C Duration: 3 days
Effect : Yes, in vitro effects: Cytopathic effects (intracellular inclusions) in tissue culture which may be visualized by appropriate conjugated antibodies
Comments : Forms intracellular inclusions which react with specific anti-C. pneumoniae monoclonal antibodies and monoclonal antibodies directed against the chlamydia LPS (genus antigen: Kallestad C. trachomatis Culture Confirmation System). Will not stain with iodine or monoclonal antibodies against the MOMP of C. trachomatis. Infection is enhanced by centrifugation and use of cycloheximide (1-2ug/ml) in medium. This preparation has tested positive for Mycoplasma contamination.
References : 32842: Chirgwin K, et al. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob. Agents Chemother. 33: 1634-1635, 1989. PubMed: 2817862
Classification: Chlamydiacea, Chlamydophila
Agent: Chlamydophila pneumoniae deposited as Chlamydia pneumoniae Grayston et al.
Strain: TWAR strain 2043
Original Source: nasopharynx of human patient with pneumonia
Depositors: MR Hammerschlag
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : HEp-2 cells (ATCCCCL-23) HeLa 229 cells (ATCCCCL-2.1) human; human cell lines
Incubation : Atmosphere: 5% CO2 in air recommended Temperature: 35.0°C Duration: 3 days
Effect : Yes, in vitro effects: Cytopathic effects (intracellular inclusions) in tissue culture which may be visualized by appropriate conjugated antibodies
Comments : Forms intracellular inclusions which react with specific anti-C. pneumoniae monoclonal antibodies and monoclonal antibodies directed against the chlamydia LPS (genus antigen: Kallestad C. trachomatis Culture Confirmation System). Will not stain with iodine or monoclonal antibodies against the MOMP of C. trachomatis. Infection is enhanced by centrifugation and use of cycloheximide (1-2ug/ml) in medium. This preparation has tested positive for Mycoplasma contamination.
References : 32842: Chirgwin K, et al. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR). Antimicrob. Agents Chemother. 33: 1634-1635, 1989. PubMed: 2817862
